# Baxalta US Incorporated – FDA Inspection, Nov 2, 2018

Source: https://www.keypedia.com/records/fda_inspections/baxalta-us-incorporated/4005c3a2-d95d-40ae-a3b6-adc953482e8b
Source feed: FDA_Inspections

> FDA inspection 1072937 of Baxalta US Incorporated, November 02, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1072937
- Company Name: Baxalta US Incorporated
- Inspection Date: 2018-11-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1287588 - 2025-11-07
- [FDA Inspection 1208375 - 2023-05-31](https://www.keypedia.com/records/fda_inspections/baxalta-us-incorporated/f54694b5-ae3d-4d13-b692-423ba650590b)
- [FDA Inspection 998105 - 2016-12-13](https://www.keypedia.com/records/fda_inspections/baxalta-us-incorporated/607da296-d988-451a-b214-a178ebb16585)
- FDA Inspection 923173 - 2015-03-13
- FDA Inspection 801949 - 2012-09-20

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/abby-l-mozeke/ce4ecbbc-0108-483e-aff3-d5320e50114f)
- Issuing Officer

Company: https://www.keypedia.com/companies/baxalta-us-incorporated/bb2b5b07-7c9c-4fce-b969-4dc5fa402b64

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
